RT Journal Article
SR Electronic
T1 Association of demographic and occupational factors with SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: a rapid real-world analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.11.21251548
DO 10.1101/2021.02.11.21251548
A1 Martin, Christopher A.
A1 Marshall, Colette
A1 Patel, Prashanth
A1 Goss, Charles
A1 Jenkins, David R.
A1 Ellwood, Claire
A1 Barton, Linda
A1 Price, Arthur
A1 Brunskill, Nigel J.
A1 Khunti, Kamlesh
A1 Pareek, Manish
YR 2021
UL http://medrxiv.org/content/early/2021/02/13/2021.02.11.21251548.abstract
AB Background Healthcare workers (HCWs) and ethnic minority groups are at increased risk of COVID-19 infection and adverse outcome. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination is now available for frontline UK HCWs; however, demographic/occupational associations with vaccine uptake in this cohort are unknown. We sought to establish these associations in a large UK hospital workforce.Methods We conducted cross-sectional surveillance examining vaccine uptake amongst all staff at University Hospitals of Leicester NHS Trust. We examined proportions of vaccinated staff stratified by demographic factors, occupation and previous COVID-19 test results (serology/PCR) and used logistic regression to identify predictors of vaccination status after adjustment for confounders.Findings We included 19,044 HCWs; 12,278 (64.5%) had received SARS-CoV-2 vaccination. Compared to White HCWs (70.9% vaccinated), a significantly smaller proportion of ethnic minority HCWs were vaccinated (South Asian 58.5%, Black 36.8% p<0.001 for both). After adjustment, factors found to be negatively associated with vaccine uptake were; younger age, female sex, increasing deprivation and belonging to any non-White ethnic group (Black: aOR0.30, 95%CI 0.26–0.34, South Asian:0.67, 0.62–0.72). Allied health professionals and administrative/executive staff were more likely to be vaccinated than doctors.Interpretation Ethnic minority HCWs and those from more deprived areas as well as those from particular occupational groups are less likely to take up SARS-CoV-2 vaccination. These findings have major implications for the delivery of SARS-CoV-2 vaccination programmes, in HCWs and the wider population and should inform the national vaccination programme to prevent the disparities of the pandemic from widening.Funding NIHR, UKRI/MRCCompeting Interest StatementDr. Pareek reports grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work. Prof. Khunti is a member of Independent SAGE and national lead for ethnicity and diversity for National Institute for Health Applied Research Collaborations and Director for University of Leicester Centre for Black Minority Ethnic Health.Funding StatementCAM is an NIHR academic clinical fellow (ACF-2018-11-004). KK is supported by NIHR Applied Research Collaboration East Midlands (ARC EM). KK and MP are supported by the NIHR Leicester Biomedical Research Centre (BRC). MP is supported by a NIHR Development and Skills Enhancement Award and funding from UKRI/MRC (MR/V027549/1). The views expressed are those of the author(s) and not necessarily those of the NIHR, NHS or the Department of Health and Social Care. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We consulted the NHS Health Research Authority decision aid to ascertain whether ethical approval was required. It was deemed that, as this work represents a service evaluation/surveillance which utilises data collected as part of the routine delivery of a clinical service, approval was not required. In addition, we confirmed approval from our Caldicott Guardian to undertake this work as an audit (UHL11113).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe patient cohort was extracted under Caldicott Guardian approval for a specific purpose and as part of our undertaking with them we are not to further routinely share this data. The data is held in an institutional repository and interested parties, with appropriate approvals, can apply for data access through the Corresponding author. Reasonable requests will be assessed on a case-by-case basis in discussion with the Caldicott Guardian.